CHINA SHINEWAY PHARMACEUTICAL GR financial statements, including revenue, expenses, profit, and loss

The total revenue of 2877 for the last semiannual is 2.29 B HKD, and it's 15.66% lower compared to the previous semiannual. The net income of H2 23 is 516.45 M HKD.